Regulation of ABCA1 by AMD-Associated Genetic Variants and Hypoxia in iPSC-RPE.
Florian PetersLynn J A EbnerDavid AtacJordi MaggiWolfgang BergerAnneke I den HollanderChristian GrimmPublished in: International journal of molecular sciences (2022)
Age-related macular degeneration (AMD) is a progressive disease of the macula characterized by atrophy of the retinal pigment epithelium (RPE) and photoreceptor degeneration, leading to severe vision loss at advanced stages in the elderly population. Impaired reverse cholesterol transport (RCT) as well as intracellular lipid accumulation in the RPE are implicated in AMD pathogenesis. Here, we focus on ATP-binding cassette transporter A1 (ABCA1), a major cholesterol transport protein in the RPE, and analyze conditions that lead to ABCA1 dysregulation in induced pluripotent stem cell (iPSC)-derived RPE cells (iRPEs). Our results indicate that the risk-conferring alleles rs1883025 (C) and rs2740488 (A) in ABCA1 are associated with increased ABCA1 mRNA and protein levels and reduced efficiency of cholesterol efflux from the RPE. Hypoxia, an environmental risk factor for AMD, reduced expression of ABCA1 and increased intracellular lipid accumulation. Treatment with a liver X receptor (LXR) agonist led to an increase in ABCA1 expression and reduced lipid accumulation. Our data strengthen the homeostatic role of cholesterol efflux in the RPE and suggest that increasing cellular cholesterol export by stimulating ABCA1 expression might lessen lipid load, improving RPE survival and reducing the risk of developing AMD.
Keyphrases
- age related macular degeneration
- binding protein
- low density lipoprotein
- poor prognosis
- stem cells
- endothelial cells
- reactive oxygen species
- transcription factor
- early onset
- risk assessment
- climate change
- amino acid
- electronic health record
- bone marrow
- cell cycle arrest
- free survival
- dna binding
- cell therapy
- smoking cessation
- life cycle
- community dwelling